JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 116 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $79,405 | -43.6% | 42,922 | -66.1% | 0.00% | – |
| Q4 2022 | $140,688 | +37119.0% | 126,746 | -21.5% | 0.00% | – |
| Q3 2022 | $378 | -39.0% | 161,519 | -21.1% | 0.00% | – |
| Q2 2022 | $620 | -100.0% | 204,633 | -47.8% | 0.00% | -100.0% |
| Q1 2022 | $2,661,000 | -55.8% | 391,916 | -45.6% | 0.00% | 0.0% |
| Q4 2021 | $6,016,000 | +20.2% | 720,445 | +6.9% | 0.00% | 0.0% |
| Q3 2021 | $5,007,000 | +347.9% | 673,926 | +310.1% | 0.00% | – |
| Q2 2021 | $1,118,000 | -28.1% | 164,349 | +8.6% | 0.00% | – |
| Q1 2021 | $1,554,000 | +524.1% | 151,311 | +325.7% | 0.00% | – |
| Q4 2020 | $249,000 | -19.7% | 35,547 | -6.7% | 0.00% | – |
| Q3 2020 | $310,000 | -20.9% | 38,087 | -33.0% | 0.00% | – |
| Q2 2020 | $392,000 | +3.2% | 56,872 | -28.9% | 0.00% | – |
| Q1 2020 | $380,000 | -60.8% | 79,962 | -27.9% | 0.00% | – |
| Q4 2019 | $969,000 | +112.5% | 110,966 | -18.9% | 0.00% | – |
| Q3 2019 | $456,000 | -1.7% | 136,789 | +46.0% | 0.00% | – |
| Q2 2019 | $464,000 | -17.1% | 93,675 | +3.7% | 0.00% | – |
| Q1 2019 | $560,000 | +74.5% | 90,301 | -5.2% | 0.00% | – |
| Q4 2018 | $321,000 | -51.4% | 95,222 | -6.4% | 0.00% | – |
| Q3 2018 | $661,000 | +2.8% | 101,738 | +21.1% | 0.00% | – |
| Q2 2018 | $643,000 | -62.5% | 83,996 | +9.4% | 0.00% | – |
| Q1 2018 | $1,716,000 | +117.8% | 76,780 | +24.3% | 0.00% | – |
| Q4 2017 | $788,000 | -56.0% | 61,787 | -46.3% | 0.00% | – |
| Q3 2017 | $1,791,000 | +83.3% | 114,962 | +65.1% | 0.00% | – |
| Q2 2017 | $977,000 | +260.5% | 69,648 | +465.7% | 0.00% | – |
| Q1 2017 | $271,000 | – | 12,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|